Clinical Trial

CIBMTR Research Database

Recruiting
View on ClinicalTrials.gov →
Summary
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies. A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries. Objectives: To learn more about what makes stem cell transplants and cellular therapies work well such as: * Determine how well recipients recover from their transplants or cellular therapy; * Determine how recovery after a transplant or cellular therapy can be improved; * Determine how a donor's or recipient's genetics impact recipient recovery after a transplant or cellular therapy; * Determine how access to transplant or cellular therapy for different groups of patients can be improved; * Determine how well donors recover from the collection procedures.
Protocol Amendment History 18 amendments
This ClinicalTrials.gov record has been amended 18 times since 2010-07-19; most recent amendment 2025-08-07.
Trial Details
NCT Number NCT01166009
Lead Sponsor Center for International Blood and Marrow Transplant Research
Conditions Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Solid Tumors, Blood Cancers, CAR-T, Gene Therapy, Non-malignant Disease
Enrollment 99,999,999 participants
Start Date 2002-07
Primary Completion 2050-07 (estimated)
Study Completion 2050-07 (estimated)
Updated on ClinicalTrials.gov 2025-08-12